1985
DOI: 10.1016/0014-5793(85)81270-9
|View full text |Cite
|
Sign up to set email alerts
|

Thioridazine: a selective inhibitor of peroxisomal β‐oxidation in vivo

Abstract: In vivo administration of the phenothiazine drug, thioridazine, inhibits hepatic peroxisomal fl-oxidation in mice. In starving animals, 3-hydroxybutyrate concentration is not decreased by thioridazine treatment. These results provide the first demonstration of thioridazine as a selective inhibitor of peroxisomal /I-oxidation in intact animals. Thioridazine might supply a tool for simulation of pathological conditions in which peroxisomal #&oxidation is impaired. Peroxisome ~-Oxidation CatalaseIn vivo inkibit~on Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
31
0

Year Published

1986
1986
2005
2005

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 43 publications
(32 citation statements)
references
References 15 publications
1
31
0
Order By: Relevance
“…The activity of peroxi-soma1 B-oxidation, which produces H202 in the first step (Lazarow & de Duve 1976), was determined by measuring H202 generation. Van den Branden & Roels (1985) showed, by estimation of residual catalase activity, that in-vivo administration of thioridazine inhibited hepatic peroxisomal /?-oxidation in mice; they also showed that 3hydroxybutyrate concentration was not reduced by thioridazine treatment (50-250 pmol kg-' , in saline, given intraperitoneally) in fed or 24-h-starved mice. They subsequently discussed the short-and long-term influence of phenothiazines on liver peroxisomal fatty acid oxidation in rodents (Van den Branden et a1 1987).…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations
“…The activity of peroxi-soma1 B-oxidation, which produces H202 in the first step (Lazarow & de Duve 1976), was determined by measuring H202 generation. Van den Branden & Roels (1985) showed, by estimation of residual catalase activity, that in-vivo administration of thioridazine inhibited hepatic peroxisomal /?-oxidation in mice; they also showed that 3hydroxybutyrate concentration was not reduced by thioridazine treatment (50-250 pmol kg-' , in saline, given intraperitoneally) in fed or 24-h-starved mice. They subsequently discussed the short-and long-term influence of phenothiazines on liver peroxisomal fatty acid oxidation in rodents (Van den Branden et a1 1987).…”
Section: Discussionmentioning
confidence: 98%
“…Rats were killed by decapitation 2 h after intraperitoneal injection of 3-amino-1,2,4-triazole (1 g kg-' in 0.9% NaCl (saline))-methanol(3.5 mmol kg-I), an inhibitor of catalase-hydrogen peroxide complex (Oshino et a1 1973;Inestrosa et a1 1979;Mannaerts et a1 1979;Leighton et a1 1984;Van den Branden et a1 1984;Van den Branden & Roels 1985;Small et a1 1985;Van den Branden et a1 1987;Skorin et a1 1992). The liver was quickly removed and weighed and a portion was quickly frozen with blocks of dry ice and finely powdered.…”
Section: Animal Experimentsmentioning
confidence: 99%
See 1 more Smart Citation
“…Inhibition of peroxisomal beta-oxidation in vivo is achieved by administration of thioridazine, a phenothiazine drug (Van den Branden and Roels, 1985) for 2 weeks from day 8 till day 21, matching the period of maximal myelination with the effectivity range of the drug ( Van den Branden et al, 1987a). Preliminary results were published (Van den Branden et al, 1987b,c).…”
Section: Introductionmentioning
confidence: 99%
“…An impairment of the former system resulting in the accumulation of VLCFA in body fluids and tissues exists in patients with peroxisomal diseases [2]. Although phenothiazines were demonstrated in rodent liver to inhibit peroxisomal &oxidation [3,4], no animal model for the chronic depression of this route has been studied.…”
Section: Introductionmentioning
confidence: 99%